| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | 7.972 | 0 | 67.922 | 97.591 | 0 | 176.870 | 282.924 | 24.960 |
| Total Income - EUR | - | - | 7.972 | 30 | 68.373 | 97.591 | 0 | 177.743 | 284.604 | 25.187 |
| Total Expenses - EUR | - | - | 335 | 9.793 | 57.656 | 99.507 | 2.454 | 53.600 | 158.949 | 46.445 |
| Gross Profit/Loss - EUR | - | - | 7.637 | -9.763 | 10.718 | -1.916 | -2.454 | 124.143 | 125.655 | -21.258 |
| Net Profit/Loss - EUR | - | - | 7.398 | -9.764 | 8.667 | -2.794 | -2.454 | 122.402 | 123.250 | -21.470 |
| Employees | - | - | 0 | 0 | 0 | 1 | 1 | 1 | 1 | 1 |
Check the financial reports for the company - Fibromed Technology S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | 32 | 0 | 0 | 2.064 | 1.575 | 1.135 | 1.733 | 1.560 |
| Current Assets | - | - | 8.476 | 3.245 | 114.254 | 7.836 | 5.426 | 181.045 | 313.844 | 290.059 |
| Inventories | - | - | 0 | 0 | 98.352 | 0 | 0 | 0 | 0 | 79.950 |
| Receivables | - | - | 3.558 | 603 | 4.463 | 667 | 718 | 28.971 | 27.983 | 6.543 |
| Cash | - | - | 4.918 | 2.642 | 11.438 | 7.169 | 4.709 | 152.074 | 285.862 | 203.567 |
| Shareholders Funds | - | - | 7.507 | -2.394 | 6.319 | 3.405 | 876 | 123.281 | 246.157 | 223.311 |
| Social Capital | - | - | 109 | 107 | 105 | 103 | 101 | 101 | 101 | 101 |
| Debts | - | - | 1.000 | 5.639 | 107.935 | 6.494 | 6.125 | 58.899 | 69.420 | 68.309 |
| Income in Advance | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "4646 - 4646" | |||||||||
| CAEN Financial Year |
4646
|
|||||||||
Comments - Fibromed Technology S.r.l.